Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression
- PMID: 25885012
- PMCID: PMC4403019
- DOI: 10.1089/cap.2014.0097
Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression
Abstract
Objective: The purpose of this study was to examine the satisfaction of families who participated in the Treatment of Severe Childhood Aggression (TOSCA) study.
Methods: TOSCA was a randomized clinical trial of psychostimulant plus parent training plus placebo (basic treatment) versus psychostimulant plus parent training plus risperidone (augmented treatment) for children with severe physical aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. Parents completed a standardized Parent Satisfaction Questionnaire (PSQ).
Results: Of the 168 families randomized, 150 (89.3%) provided consumer satisfaction data. When they were asked if they would join the study again if they had the option to repeat, 136 (91%) said "yes," 11 (7%) said "maybe," and one (<1%) said "no." When asked if they would recommend the study to other parents with children having similar problems, 147 (98%) said "yes" and 3 (2%) said "maybe." Between 71% (rating one aspect of the Parent Training) and 96% (regarding the diagnostic interview) endorsed study procedures using the most positive response option. Asked if there were certain aspects of the study that they especially liked, 64 (43%) spontaneously reported parent training. Treatment assignment (basic vs. augmented) and responder status were not associated with reported satisfaction. However, responder status was strongly associated with parent confidence in managing present (p<0.001) and future (p<0.005) problem behaviors.
Conclusions: These findings indicate high levels of satisfaction with TOSCA study involvement and, taken together with previous pediatric psychopharmacology social validity studies, suggest high levels of support for the research experience. These findings may inform research bioethics and may have implications for deliberations of institutional review boards.
Trial registry: Treatment of Severe Childhood Aggression (The TOSCA Study), NCT00796302, clinicaltrials.gov .
References
-
- Ahmed K, Bhugra D: Depression across ethnic minority cultures: Diagnostic issues. World Cultural Psychiatry Rese Rev Apr-Jul:47–56, 2007
-
- Aman M, Bukstein O, Gadow K, Arnold L, Molina B, McNamara N, Rundberg–Rivera V, Li X, Kipp H, Schneider J, Butter E, Baker J, Sprafkin J, Rice R, Bangalore S, Farmer C, Austin A, Buchan–Page K, Brown N, Hurt E, Grondhuis S, Findling R: What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 53:47–60, 2014 - PMC - PubMed
-
- Aman MG, Farmer CA: Psychotropic medication research in children and adolescents: Ethical implications. J Empir Res Hum Res Ethics 3:39–47, 2008 - PubMed
-
- Aman M, Leone S, Lecavalier L, Park L, Buican B, Coury D: The Nisonger child behavior rating form: Typical IQ version. Int Clin Psychopharmacol 23:232–242, 2008 - PubMed
-
- Aman MG, Wolford PL. Consumer satisfaction with involvement in drug research: a social validity study. J Am Acad Child Adolesc Psychiatry 34:940–945, 1995 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
